Induction of a 55-kDa PKN cleavage product by ischemia/reperfusion model in the rat retina
- PMID: 10634597
Induction of a 55-kDa PKN cleavage product by ischemia/reperfusion model in the rat retina
Abstract
Purpose: To investigate the physiological role of a protein kinase, PKN, and its relation to apoptosis in vivo.
Methods: An ischemia/reperfusion model of the rat retina was created by elevating the intraocular pressure. Retinal samples were obtained after ischemic insult (15-45 minutes) followed by reperfusion (1-7 days). The effect of ischemia on the fragmentation of PKN was examined by immunoblotting and immunocytochemical procedures using the antibody against PKN. N-methyl-D-aspartate (NMDA) or a caspase-3 inhibitor (DEVD-CHO) was administered intravitreally to investigate its effect on the induction of PKN fragmentation. The retinal cell loss in each sample was evaluated by toluidine blue staining.
Results: Ischemia induced a 55-kDa PKN cleavage fragment corresponding to the molecular size of the constitutively active fragment of PKN. The appearance of the cleavage fragment depended on the duration of reperfusion and correlated with the occurrence of retinal cell loss. Immunocytochemical analysis revealed that ischemia increased PKN immunoreactivity in the inner layers of the retina. DEVD-CHO significantly inhibited the appearance of the 55-kDa fragment and protected against retinal cell loss. The administration of NMDA also induced cleavage of PKN.
Conclusions: PKN is specifically cleaved by caspase-3 or a related protease during apoptosis in vivo, and PKN cleavage is at least partially initiated by activation of the NMDA receptor.
Similar articles
-
Apoptosis and caspases after ischemia-reperfusion injury in rat retina.Invest Ophthalmol Vis Sci. 1999 Apr;40(5):967-75. Invest Ophthalmol Vis Sci. 1999. PMID: 10102294
-
Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases.Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2697-705. Invest Ophthalmol Vis Sci. 1999. PMID: 10509668
-
Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage.Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3210-4. Invest Ophthalmol Vis Sci. 2000. PMID: 10967085
-
[Changes of expression of the P38 MAPK and caspase-3 in rat retinal ischemia-reperfusion model and the influence of Nimodipine].Zhonghua Yan Ke Za Zhi. 2006 May;42(5):435-42. Zhonghua Yan Ke Za Zhi. 2006. PMID: 16762239 Chinese.
-
[Protein kinase PKN].Seikagaku. 1998 Nov;70(11):1335-9. Seikagaku. 1998. PMID: 9889594 Review. Japanese. No abstract available.
Cited by
-
PKN1 Exerts Neurodegenerative Effects in an In Vitro Model of Cerebellar Hypoxic-Ischemic Encephalopathy via Inhibition of AKT/GSK3β Signaling.Biomolecules. 2023 Oct 31;13(11):1599. doi: 10.3390/biom13111599. Biomolecules. 2023. PMID: 38002281 Free PMC article.
-
Role of PKN1 in Retinal Cell Type Formation.Int J Mol Sci. 2024 Feb 29;25(5):2848. doi: 10.3390/ijms25052848. Int J Mol Sci. 2024. PMID: 38474095 Free PMC article.
-
Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.Circ Res. 2010 Sep 3;107(5):642-9. doi: 10.1161/CIRCRESAHA.110.217554. Epub 2010 Jul 1. Circ Res. 2010. PMID: 20595653 Free PMC article.
-
PKN3 is the major regulator of angiogenesis and tumor metastasis in mice.Sci Rep. 2016 Jan 8;6:18979. doi: 10.1038/srep18979. Sci Rep. 2016. PMID: 26742562 Free PMC article.
-
Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.Cardiovasc Res. 2018 Jan 1;114(1):138-157. doi: 10.1093/cvr/cvx206. Cardiovasc Res. 2018. PMID: 29045568 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
